Mucosal Immunity
7
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (7)
Multi-Strain Probiotic Supplementation, Salivary Immunity, and Upper Respiratory Symptoms in Trained Athletes
Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race
Neutralizing Power of Serum Antibodies - 2
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
Strategies for Enhancing Mucosal Immunity to Influenza Vaccine